Market Cap 5.11M
Revenue (ttm) 1.50M
Net Income (ttm) -12.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -864.00%
Debt to Equity Ratio 0.00
Volume 89,800
Avg Vol 2,593,914
Day's Range N/A - N/A
Shares Out 6.99M
Stochastic %K 28%
Beta 1.42
Analysts Strong Sell
Price Target $5.33

Company Profile

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers; and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid...

Industry: Biotechnology
Sector: Healthcare
Phone: 215 948 4119
Website: aprea.com
Address:
3805 Old Easton Road, Doylestown, United States
erb71
erb71 Mar. 20 at 2:27 PM
$APRE That is the reason I continue holding: https://aprea.com/aprea-therapeutics-pipeline/ (not advice, everyone is responsible for their own DD and decisions)
0 · Reply
erb71
erb71 Mar. 19 at 6:08 PM
$APRE The falling wedges on the weekly chart indicate even higher potential targets than those on the bullish patterns on the daily chart, the former ranging between $10 and $80, while the latter between $2.4 and $5.3. The MACD 12-26 appears to be stabilised over the last few years. A critical indicator is the shape of VRVPs. They become much shallower above $2, and almost indiscernible between $10 and $95. Another development is that, according to iBorrowDesk, the number of available borrowable shares is at its highest level since at least last April, suggesting that shorts are refraining from short-selling it. If there are more promising trial results or increased expectations for such outcomes, it may have an indefinite upside potential, given the significant liquidity gaps above $2 and then over $10. (not advice, just observations and probabilities)
0 · Reply
Captain_crack
Captain_crack Mar. 19 at 1:16 PM
$APRE .45-.65
0 · Reply
PTI127
PTI127 Mar. 18 at 7:19 PM
$APRE @StockAuthority can u buying lots of shares in $APRE IM wondering 🤔 you still have them
0 · Reply
Captain_crack
Captain_crack Mar. 17 at 8:19 PM
$APRE .65
0 · Reply
erb71
erb71 Mar. 16 at 4:18 PM
$APRE The patterns mentioned in the post below remain in effect (not advice, just observations and probabilities)
2 · Reply
Captain_crack
Captain_crack Mar. 16 at 1:55 PM
$APRE buyer at .45
0 · Reply
erb71
erb71 Mar. 13 at 5:10 PM
$APRE I reckon, given the latest trial results, shorts are more aware of its upside potential than the overall market. They appear to have refrained from shorting it since mid-February, and the available borrowable shares have mostly remained above 600K, not far from the recent maximum of 850K. Based on the news, there may be a breakthrough ahead, provided that new positive results are obtained over the next phases of trials. Meanwhile, on the daily chart, both a double bottom and a falling wedge remain in progress, indicating potential targets of $2.43 and $5.27, respectively, if validated (not advice)
0 · Reply
Captain_crack
Captain_crack Mar. 13 at 4:57 PM
$APRE back to .40
0 · Reply
Captain_crack
Captain_crack Mar. 12 at 5:21 AM
$APRE glad I sold this
0 · Reply
Latest News on APRE
Aprea Therapeutics to Present at DDR Inhibitors Summit 2024

Jan 30, 2024, 8:00 AM EST - 2 years ago

Aprea Therapeutics to Present at DDR Inhibitors Summit 2024


erb71
erb71 Mar. 20 at 2:27 PM
$APRE That is the reason I continue holding: https://aprea.com/aprea-therapeutics-pipeline/ (not advice, everyone is responsible for their own DD and decisions)
0 · Reply
erb71
erb71 Mar. 19 at 6:08 PM
$APRE The falling wedges on the weekly chart indicate even higher potential targets than those on the bullish patterns on the daily chart, the former ranging between $10 and $80, while the latter between $2.4 and $5.3. The MACD 12-26 appears to be stabilised over the last few years. A critical indicator is the shape of VRVPs. They become much shallower above $2, and almost indiscernible between $10 and $95. Another development is that, according to iBorrowDesk, the number of available borrowable shares is at its highest level since at least last April, suggesting that shorts are refraining from short-selling it. If there are more promising trial results or increased expectations for such outcomes, it may have an indefinite upside potential, given the significant liquidity gaps above $2 and then over $10. (not advice, just observations and probabilities)
0 · Reply
Captain_crack
Captain_crack Mar. 19 at 1:16 PM
$APRE .45-.65
0 · Reply
PTI127
PTI127 Mar. 18 at 7:19 PM
$APRE @StockAuthority can u buying lots of shares in $APRE IM wondering 🤔 you still have them
0 · Reply
Captain_crack
Captain_crack Mar. 17 at 8:19 PM
$APRE .65
0 · Reply
erb71
erb71 Mar. 16 at 4:18 PM
$APRE The patterns mentioned in the post below remain in effect (not advice, just observations and probabilities)
2 · Reply
Captain_crack
Captain_crack Mar. 16 at 1:55 PM
$APRE buyer at .45
0 · Reply
erb71
erb71 Mar. 13 at 5:10 PM
$APRE I reckon, given the latest trial results, shorts are more aware of its upside potential than the overall market. They appear to have refrained from shorting it since mid-February, and the available borrowable shares have mostly remained above 600K, not far from the recent maximum of 850K. Based on the news, there may be a breakthrough ahead, provided that new positive results are obtained over the next phases of trials. Meanwhile, on the daily chart, both a double bottom and a falling wedge remain in progress, indicating potential targets of $2.43 and $5.27, respectively, if validated (not advice)
0 · Reply
Captain_crack
Captain_crack Mar. 13 at 4:57 PM
$APRE back to .40
0 · Reply
Captain_crack
Captain_crack Mar. 12 at 5:21 AM
$APRE glad I sold this
0 · Reply
Captain_crack
Captain_crack Mar. 11 at 4:29 PM
$APRE easiest short. Dog shit company. No fundamentals no buying
0 · Reply
Captain_crack
Captain_crack Mar. 11 at 2:54 PM
$APRE .75
0 · Reply
Captain_crack
Captain_crack Mar. 11 at 2:41 PM
$APRE just dumped 25000 shares for a slight loss. Buying back shares lower 🤣
0 · Reply
Captain_crack
Captain_crack Mar. 11 at 2:37 PM
$APRE buyer at .35-.55
0 · Reply
Captain_crack
Captain_crack Mar. 11 at 2:24 PM
$APRE whoever is wanting to bu shares at .69 selling you my 20,000 shares. I’ll dump it back to .40
0 · Reply
Captain_crack
Captain_crack Mar. 11 at 1:56 PM
$APRE this is headed back to .60s. People bought at .60 and now have sold leaving retail to bag hold. Dumping my shares
0 · Reply
Captain_crack
Captain_crack Mar. 11 at 1:37 PM
$APRE get me out of this stock
0 · Reply
Captain_crack
Captain_crack Mar. 10 at 11:55 PM
$APRE $1 imo
0 · Reply
forallthedogs
forallthedogs Mar. 10 at 10:08 PM
$APRE yea it seems they are throwing up walls now I see 1000 share wall at 93 cents on level 2
2 · Reply
Captain_crack
Captain_crack Mar. 10 at 9:06 PM
$APRE push to .95 let’s go
1 · Reply
Captain_crack
Captain_crack Mar. 10 at 8:05 PM
$APRE I requested to buy at $1 did 30 shares and filled at .90
1 · Reply
forallthedogs
forallthedogs Mar. 10 at 8:04 PM
$APRE same just slap the ask its back up again lol
0 · Reply